Medical Equipment

Organoid Kit Industry Forecast to Hit $2.37 Billion by 2029 With a Strong 16% CAGR

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Organoid Kit Market Size During 2025–2029?

The organoid kit market has seen substantial expansion in recent years. Its size is anticipated to climb from $1.13 billion in 2024 to $1.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.4%. This past growth is largely driven by factors such as increased research in stem cell biology, broader applications in drug toxicity testing, more widespread use of organoids in cancer research, improved access to specialized cell culture media, and the growing importance of testing models that are free of animal components.

The organoid kit market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a value of $2.37 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.0%. Several factors are expected to drive this growth during the forecast period, including increased integration with artificial intelligence (AI) and automation, a surge in the application of organoids for gene editing, the expansion of customized organoid kit development, a boost in funding for advanced 3D bioprinting technologies, and the rising adoption of organoids for modeling rare diseases. Key trends anticipated during this period involve progress in organ-on-a-chip technology, the incorporation of AI for personalized medical treatments, novel developments in 3D cell culture systems, the broadening of organoid-based platforms for drug discovery, and increased partnerships between biotechnology companies and academic institutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28286&type=smp

What Are The Drivers Pushing New Developments In The Organoid Kit Market?

A rising occurrence of infectious diseases is anticipated to drive forward the expansion of the organoid kit market. These diseases are defined as ailments resulting from disease-causing microorganisms, including bacteria, viruses, fungi, or parasites, capable of transmission between individuals through direct or indirect means. The surge in infectious diseases stems from inadequate sanitation and congested living conditions, which facilitate the easier spread of pathogens and higher rates of infection. Organoid kits are instrumental in combating infectious diseases by empowering researchers to create models of human tissues in laboratory settings, thereby permitting accurate investigation of pathogen characteristics, infection pathways, and the evaluation of prospective therapies. For example, the UK Health Security Agency (UKHSA), a government body based in the UK, indicated that in 2025, tuberculosis (TB) continues to pose a substantial public health issue within England. Furthermore, current statistics reveal an 11% rise in documented tuberculosis cases, amounting to almost 500 more notifications, as numbers climbed from 4,380 in 2022 to 4,855 in 2023. Consequently, the expanding occurrence of infectious diseases is fueling the advancement of the organoid kit market.

Which Key Segments Fueling The Organoid Kit Market?

The organoid kit market covered in this report is segmented as

1) By Type, Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types

2) By Technology, 3D Cell Culture Technology, Microfluidics Technology, Bioprinting Technology, Electrospinning Technology

3) By Source, Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids

4) By Application, Drug Discovery and Development, Disease Modeling, Personalized Medicine, Regenerative Medicine, Other Applications

5) By End-User, Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies

Subsegments:

1) By Brain Organoids, Cerebral Organoids, Midbrain Organoids, Retinal Organoids

2) By Kidney Organoids, Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids

3) By Intestinal Organoids, Small Intestine Organoids, Colon Organoids, Gastric Organoids

4) By Liver Organoids, Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids

5) By Other Organoid Types, Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids

What Key Innovation Trends Are Fueling Advancements In The Organoid Kit Market?

Major companies in the organoid kit market are concentrating on developing quick aggregate formations to speed up organoid development timelines, enhance reproducibility, and enable high-throughput applications for drug discovery, disease modeling, and personalized medicine. Rapid aggregate formation describes the capacity to swiftly generate thousands of uniform pluripotent stem cell aggregates in a single day, significantly reducing the overall organoid development period. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, launched its PluriForm Organoid Kit. This kit is designed to simplify the creation of pluripotent stem cell aggregates and accelerate organoid development. It offers a ready-to-use platform that shortens the timeline for producing mature organoids from months to just weeks. The kit integrates optimized growth media and standardized protocols, which ensures reproducible results across various cell types, and supports high-throughput applications, making it suitable for large-scale disease modeling and drug screening.

Which Major Industry Participants Are Leading The Organoid Kit Market Growth?

Major companies operating in the organoid kit market are Thermo Fisher Scientific Inc., bioGenous Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Molecular Devices LLC, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., Crown Bioscience International, Creative Biolabs Inc., Emulate Inc., CN Bio Innovations Limited, Novoprotein Scientific Inc., MedChemExpress LLC, Xylyx Bio Inc., MIMETAS B.V., Prellis Biologics Inc., TheWell Bioscience Inc., InSCREENeX GmbH, AMS Biotechnology (Europe) Limited (AMSBIO).

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/organoid-kit-global-market-report

What Are The Key Regional Factors Influencing The Organoid Kit Market Growth?

North America was the largest region in the organoid kit market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in organoid kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Organoid Kit Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28286&type=smp

Browse Through More Reports Similar to the Global Organoid Kit Market 2025, By The Business Research Company

Organoids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Organoids And Spheroids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

Artificial Organ Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795